JNK3 as a therapeutic target for neurodegenerative diseases.
about
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnershipsc-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's DiseaseXG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study.Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.JNK isoforms differentially regulate neurite growth and regeneration in dopaminergic neurons in vitro.Deoxyribozymes: new therapeutics to treat central nervous system disordersSmall peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathwaySerine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stressThe inositol metabolism pathway as a target for neuroprotective strategies.Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy.
P2860
Q26741279-9C68504B-07C6-48C9-BF43-FF69F6BABB9EQ26770431-14241E69-BFB8-4785-9E26-867D08221AC8Q30423728-B8A273F4-89B8-4250-854D-0D313CDB49DFQ34233293-301A7645-CC95-4A90-80E0-A6108B42E080Q35228456-5C80ACD0-EF4B-4094-A719-BEA59B350AA2Q35228538-E3343C03-9E6A-420E-8ECF-132240FE6F33Q35598315-60E358D9-6CDA-4C6E-945C-ED41B0C5E748Q36451963-CE7DBF73-CF7D-45C7-A1DC-34441F414CA6Q36767908-C2944843-4DE2-48FE-8B1A-6FB36546FA9BQ41779887-209110EF-5964-487B-AFD1-05DF324E8E5DQ41981772-2D60D96C-F4D6-4692-BF9A-AC9182C2A66FQ48292161-11C9F562-4131-4848-B380-91875DA10683
P2860
JNK3 as a therapeutic target for neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
JNK3 as a therapeutic target for neurodegenerative diseases.
@en
JNK3 as a therapeutic target for neurodegenerative diseases.
@nl
type
label
JNK3 as a therapeutic target for neurodegenerative diseases.
@en
JNK3 as a therapeutic target for neurodegenerative diseases.
@nl
prefLabel
JNK3 as a therapeutic target for neurodegenerative diseases.
@en
JNK3 as a therapeutic target for neurodegenerative diseases.
@nl
P356
P1476
JNK3 as a therapeutic target for neurodegenerative diseases.
@en
P2093
Daniele Di Marino
Xanthi Antoniou
P304
P356
10.3233/JAD-2011-091567
P577
2011-01-01T00:00:00Z